EcoDrugPlus

Secretin Receptor

Ensembl ID : ENSNGAG00000003594
Gene Symbol: SCTR
3 Cross references
130 Possible Orthologues:

Sedoheptulokinase

Ensembl ID : ENSNGAG00000013930
Gene Symbol: LOC103751981
3 Cross references
134 Possible Orthologues:

Selectin E

Ensembl ID : ENSNGAG00000016163
Gene Symbol: SELE
3 Cross references
197 Possible Orthologues:

Selectin L

Ensembl ID : ENSNGAG00000020396
Gene Symbol: SELL
3 Cross references
86 Possible Orthologues:

Selectin P

Ensembl ID : ENSNGAG00000010565
Gene Symbol: SELP
3 Cross references
120 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSNGAG00000017331
Gene Symbol: SERPINC1
3 Cross references
199 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSNGAG00000019443
Gene Symbol: SIGMAR1
3 Cross references
204 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSNGAG00000019312
Gene Symbol: SMO
3 Cross references
204 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Alpha

Ensembl ID : ENSNGAG00000019351
Gene Symbol: SCNN1A
3 Cross references
153 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Beta

Ensembl ID : ENSNGAG00000024286
Gene Symbol: SCNN1B
3 Cross references
151 Possible Orthologues:

Sodium Channel Epithelial 1 Subunit Gamma

Ensembl ID : ENSNGAG00000001538
Gene Symbol: SCNN1G
3 Cross references
155 Possible Orthologues:

Sodium Channel Protein Type 1 Subunit Alpha

Ensembl ID : ENSNGAG00000023182
Gene Symbol: LOC103732330
3 Cross references
139 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).